-
Mashup Score: 1TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD - 2 month(s) ago
Percutaneous treatment was linked to improved survival and fewer adverse events than surgery when patients presented with both symptomatic severe aortic stenosis and complex coronary artery disease.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0TAVR survival less likely when patients are depressed - 2 month(s) ago
Screening TAVR patients for signs of depression prior to treatment could help providers adapt as necessary and deliver better patient care.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
#TAVR survival less likely when patients are depressed @ACCinTouch @JACCjournals @ACCmediacenter #cardiology https://t.co/TwjYiHz0lu
-
-
Mashup Score: 3Newest TAVR valve from Edwards linked to better 1-year outcomes than its predecessors - 3 month(s) ago
The Sapien 3 Ultra Resilia TAVR valve from Edwards Lifesciences is associated with a significantly higher survival rate after one year than the company’s previous balloon-expandable valves. Researchers identified other key benefits as well, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Newest #TAVR valve from @EdwardsLifesci linked to better 1-year outcomes than its predecessors @JACCjournals @ACCmediacenter @ACCinTouch #cardiology https://t.co/gicK3TbDOI
-
-
Mashup Score: 1Prosthesis-patient mismatch after TAVR: 5 key findings related to patients with small annuli - 3 month(s) ago
PPM is still relatively common after TAVR, especially among patients with a small aortic annulus. What can be done to minimize the risk of PPM? Does valve type play a role? Researchers explored those questions, and many others.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet-
Prosthesis-patient mismatch after #TAVR: 5 key findings from new data on patients with small annuli #cardiology https://t.co/0i7tpuFoFC
-
-
Mashup Score: 2
Abbott already has an FDA-approved self-expanding TAVR valve, the Navitor system, on the market. The company is now evaluating the safety and effectiveness of a new balloon-expandable device that could potentially be implanted using software guidance.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
First patients treated with Abbott’s new balloon-expandable #TAVR valve @AbbottCardio @azeemlatib #cardiology https://t.co/3dyT8bJ66X
-
-
Mashup Score: 3Newest TAVR valve from Edwards linked to better 1-year outcomes than its predecessors - 3 month(s) ago
The Sapien 3 Ultra Resilia TAVR valve from Edwards Lifesciences is associated with a significantly higher survival rate after one year than the company’s previous balloon-expandable valves. Researchers identified other key benefits as well, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Newest #TAVR valve from @EdwardsLifesci linked to better 1-year outcomes than its predecessors @JACCjournals @ACCmediacenter @ACCinTouch #cardiology https://t.co/gicK3TbDOI
-
-
Mashup Score: 2
Self-expanding and balloon-expandable TAVR valves are associated with comparable success rates and one-year outcomes when treating type 1 bicuspid aortic stenosis. However, each valve type comes with its own advantages and disadvantages.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
How #TAVR valve choice impacts outcomes when treating type 1 bicuspid aortic stenosis #cardiology @JACCjournals @ACCinTouch @ACCmediacenter https://t.co/tYulsaLNfc
-
-
Mashup Score: 2
Self-expanding and balloon-expandable TAVR valves are associated with comparable success rates and one-year outcomes when treating type 1 bicuspid aortic stenosis. However, each valve type comes with its own advantages and disadvantages.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
How #TAVR valve choice impacts outcomes when treating type 1 bicuspid aortic stenosis #cardiology @JACCjournals @ACCinTouch @ACCmediacenter https://t.co/tYulsaLNfc
-
-
Mashup Score: 1
SOLVE-TAVI focused on the long-term impact of selecting different second-generation transcatheter heart valves and anesthesia strategies for transfemoral TAVR procedures.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet-
Self-expanding vs. balloon-expandable #TAVR valves: 5-year data highlight key similarities, differences #cardiology @MDT_Cardiac @EdwardsLifesci @ACCmediacenter @JACCjournals @ACCintouch https://t.co/cy8opfs0pd
-
-
Mashup Score: 1
SOLVE-TAVI focused on the long-term impact of selecting different second-generation transcatheter heart valves and anesthesia strategies for transfemoral TAVR procedures.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet-
Self-expanding vs. balloon-expandable #TAVR valves: 5-year data highlight key similarities, differences #cardiology @MDT_Cardiac @EdwardsLifesci @ACCmediacenter @JACCjournals @ACCintouch https://t.co/cy8opfs0pd
-
TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD #TAVR #cardiology https://t.co/vXyvFPq9cF